Ozonics International is pleased to
announce that in May 2006, a new patent pending item has been
added to its intellectual properties.
A device for determining externally
applied ozone/oxygen dosage.
Accurately gauging the total ozone dosage applied to external
medical lesions such as diabetic and decubitus skin ulcers, poorly
healing wounds, and burns, has hitherto stymied clinicians. Integrating
factors such as ozone concentration, humidity, and time of exposure
with the specific demands of the condition under treatment has
remained challenging to the proper administration of ozone prescriptions.
Ozonics International’s proprietary innovation allows the
clinician to immediately determine externally-applied ozone dosage,
thus permitting a precise delineation of treatment duration.
As of march 2006:
H5N1 avian influenza comprehensive
deactivation is the mission of this line of air disinfection units
using combined anti-viral technologies. Designed for hospital and
clinical environments, these units are suitable for spaces with
high people densities, such as waiting rooms and airport lounges,
and schools where airborne influenza transmission is a public health
Head and neck relaxation is automatically induced with this device.
Muscle and joint tension, including TMJ, are often the cause of stress
headaches. This nonprescription device is suitable for the broad range
of individuals who seek psychological relaxation and muscular repose.